EMBC
Embecta
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: EMBC
- PE Ratio
The PE ratio for Embecta stock stands at 1.73 as of Jun 3, 2026. The calculation is based on the latest EPS of $1.92 and the stock price of $3.32 per share. A decrease of 72% has been observed in the PE ratio compared to its average of 6.2 of the past four quarters.
EMBC PE ratio history
Over the last four years, the average PE ratio of Embecta has been 11.57. The current 1.73 price-to-earnings ratio is 85% less than the historical average. Analyzing the last four years, EMBC's PE ratio reached its highest point in the Jun 2023 quarter at 24.55, with a price of $21.6 and an EPS of $0.88. The Jun 2022 quarter saw the lowest point at 4.24, with a price of $25.32 and an EPS of $5.97.
Embecta PE ratio by year
Maximum annual increase: 66.76% in 2023
Maximum annual decrease: -17.07% in 2025
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 8.6 | -17.07% | $14.11 | $1.64 |
| 2024 | 10.37 | -15.28% | $14.1 | $1.36 |
| 2023 | 12.24 | 66.76% | $15.05 | $1.23 |
| 2022 | 7.34 | N/A | $28.79 | $3.92 |
| 2021 | N/A | N/A | N/A | $7.28 |
| 2020 | N/A | N/A | N/A | $7.5 |
| 2019 | N/A | N/A | N/A | N/A |
Embecta PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 4.6 | -7.44% | $8.84 | $1.92 |
| Dec 2025 | 4.97 | -42.21% | $11.88 | $2.39 |
| Sep 2025 | 8.6 | 26.84% | $14.11 | $1.64 |
| Jun 2025 | 6.78 | -52.15% | $9.69 | $1.43 |
| Mar 2025 | 14.17 | -31.38% | $12.75 | $0.9 |
| Dec 2024 | 20.65 | 99.13% | $20.65 | $1 |
| Sep 2024 | 10.37 | -0.48% | $14.1 | $1.36 |
| Jun 2024 | 10.42 | -4.23% | $12.5 | $1.2 |
| Mar 2024 | 10.88 | -44.83% | $13.27 | $1.22 |
| Dec 2023 | 19.72 | 61.11% | $18.93 | $0.96 |
| Sep 2023 | 12.24 | -50.14% | $15.05 | $1.23 |
| Jun 2023 | 24.55 | 47.54% | $21.6 | $0.88 |
| Mar 2023 | 16.64 | 86.13% | $28.12 | $1.69 |
| Dec 2022 | 8.94 | 21.8% | $25.29 | $2.83 |
| Sep 2022 | 7.34 | 73.11% | $28.79 | $3.92 |
EMBC Price vs fair value
EMBC average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
Currently, EMBC's PE ratio is under its 3-year average.
PE comparison
Embecta's price to earnings (P/E) of 1.73 is lower than the Healthcare sector and the industry average. Looking at the Healthcare sector average of 23.02, Embecta's price to earnings (P/E) is 92% lower.
EMBC PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| EMBC Embecta Corp | 1.78 | $202.9M |
| OFIX Orthofix Medical Inc | N/A | $416.75M |
Frequently asked questions
What is Embecta's PE ratio?
The price to earnings ratio for EMBC stock is 1.73 as of Jun 3, 2026.
What is the 3-year average PE ratio for Embecta (EMBC)?
Over the last 3 years, the average PE ratio for EMBC stock is 12.33.
What is the highest PE ratio for EMBC?
The highest quarterly PE ratio in the last four years has been 24.55 and it was in the Jun 2023 quarter.
How does the current PE ratio for EMBC compare to its historical average?
EMBC's current price to earnings ratio is 85% below its 4-year historical average.
Why is Embecta's PE ratio so low?
A company with a lower PE ratio may indicate that the market has lower growth expectations for the company's future earnings.
How is EMBC's PE ratio calculated (Embecta PE ratio formula)?
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jun 3, 2026), Embecta's share price is $3.32. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $1.92. Therefore, Embecta's price to earnings ratio for today is 1.73. PE RATIO(1.73) = STOCK PRICE($3.32) / TTM EPS($1.92)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.